Beyond the platform: why surgical quality and surgeon proficiency outweigh the RATS vs. VATS debate in early-stage lung cancer - Scorecard - MDSpire

Beyond the platform: why surgical quality and surgeon proficiency outweigh the RATS vs. VATS debate in early-stage lung cancer

  • By

  • Marcello Migliore

  • Kwon Joong Na

  • July 15, 2026

Share

Clinical Scorecard: Prioritizing Surgical Expertise: The Impact of Surgeon Skill Over RATS vs. VATS in Early-Stage Lung Cancer Treatment

At a Glance

CategoryDetail
ConditionEarly-stage lung cancer
Key MechanismsSurgeon skill and lymph node dissection technique are critical for outcomes.
Target PopulationPatients with resectable non-small-cell lung cancer
Care SettingThoracic surgery

Key Highlights

  • RATS and VATS show comparable oncological outcomes.
  • Surgeon proficiency is a key determinant of surgical success.
  • RATS may facilitate better lymph node dissection due to enhanced visualization.
  • Higher costs and longer operating times are associated with RATS.
  • A tailored surgical strategy is recommended based on individual surgeon skill.

Guideline-Based Recommendations

Diagnosis

  • Assess resectability of non-small-cell lung cancer.

Management

  • Consider both RATS and VATS based on surgeon proficiency and case complexity.

Monitoring & Follow-up

  • Evaluate postoperative outcomes and complication rates for both surgical approaches.

Risks

  • Higher costs and longer operating times associated with RATS.

Patient & Prescribing Data

Patients undergoing surgical treatment for early-stage lung cancer.

Surgeons should utilize the approach that aligns with their expertise and the patient's anatomical complexity.

Clinical Best Practices

  • Prioritize surgeon skill and experience in surgical decision-making.
  • Tailor surgical approach based on individual patient needs and surgeon capabilities.
  • Maintain a focus on complete resection and adequate lymphadenectomy.

Related Resources & Content

Original Source(s)

Related Content